U.S. Physical Therapy, Inc. (NYSE:USPH) Given Average Rating of "Moderate Buy" by Brokerages

Key Points

• U.S. Physical Therapy, Inc. has received an average recommendation of "Moderate Buy" from analysts, with a 12-month target price of $110.25.
• Insider trading activity includes Nancy Ham selling 400 shares, and Graham D. Reeve selling 1,792 shares, indicating a decrease in their holdings.
• The company reported a quarterly revenue of $197.34 million, exceeding estimates and showing an 18% year-over-year increase, while also announcing a quarterly dividend of $0.45.

U.S. Physical Therapy, Inc. (NYSE:USPH - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the seven ratings firms that are presently covering the stock, MarketBeat.com reports. Two investment analysts have rated the stock with a hold recommendation, four have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is $110.25.

A number of analysts have issued reports on the company. Wall Street Zen raised U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research report on Thursday, May 8th. Zacks Research raised U.S. Physical Therapy to a "hold" rating in a research report on Friday, August 8th. Finally, Barrington Research boosted their target price on U.S. Physical Therapy from $98.00 to $103.00 and gave the company an "outperform" rating in a research report on Friday, August 8th.

U.S. Physical Therapy Trading Down 2.0%

U.S. Physical Therapy stock traded down $1.69 during mid-day trading on Monday, hitting $82.92. The company's stock had a trading volume of 78,110 shares, compared to its average volume of 143,880. The firm has a market capitalization of $1.26 billion, a PE ratio of 36.21, a price-to-earnings-growth ratio of 4.21 and a beta of 1.45. U.S. Physical Therapy has a 1 year low of $62.77 and a 1 year high of $101.19. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 0.30. The stock's fifty day moving average is $78.83 and its two-hundred day moving average is $76.85.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last issued its quarterly earnings data on Wednesday, August 6th. The company reported $0.81 earnings per share for the quarter, topping the consensus estimate of $0.71 by $0.10. The company had revenue of $197.34 million during the quarter, compared to analyst estimates of $190.24 million. U.S. Physical Therapy had a return on equity of 8.78% and a net margin of 5.05%.The firm's revenue for the quarter was up 18.0% compared to the same quarter last year. During the same period in the prior year, the business posted $0.73 earnings per share. On average, analysts anticipate that U.S. Physical Therapy will post 2.67 EPS for the current year.

U.S. Physical Therapy Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, September 12th. Shareholders of record on Friday, August 22nd will be given a $0.45 dividend. The ex-dividend date of this dividend is Friday, August 22nd. This represents a $1.80 dividend on an annualized basis and a yield of 2.2%. U.S. Physical Therapy's payout ratio is presently 78.60%.

Insider Buying and Selling at U.S. Physical Therapy

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 763 shares of the business's stock in a transaction that occurred on Thursday, August 21st. The stock was sold at an average price of $84.97, for a total value of $64,832.11. Following the sale, the chief operating officer owned 21,483 shares of the company's stock, valued at $1,825,410.51. The trade was a 3.43% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Carey P. Hendrickson sold 698 shares of the firm's stock in a transaction that occurred on Monday, August 25th. The shares were sold at an average price of $86.11, for a total transaction of $60,104.78. Following the completion of the transaction, the chief financial officer directly owned 27,808 shares of the company's stock, valued at $2,394,546.88. This represents a 2.45% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 3,653 shares of company stock valued at $311,274 over the last quarter. 2.00% of the stock is owned by company insiders.

Hedge Funds Weigh In On U.S. Physical Therapy

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Mitsubishi UFJ Asset Management Co. Ltd. increased its position in shares of U.S. Physical Therapy by 952.4% in the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 442 shares of the company's stock valued at $32,000 after purchasing an additional 400 shares during the last quarter. Cullen Frost Bankers Inc. increased its position in shares of U.S. Physical Therapy by 171.8% in the 2nd quarter. Cullen Frost Bankers Inc. now owns 443 shares of the company's stock valued at $35,000 after purchasing an additional 280 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. purchased a new stake in shares of U.S. Physical Therapy in the 4th quarter valued at approximately $39,000. Parallel Advisors LLC lifted its position in shares of U.S. Physical Therapy by 90.6% during the 2nd quarter. Parallel Advisors LLC now owns 448 shares of the company's stock worth $35,000 after buying an additional 213 shares during the last quarter. Finally, Assetmark Inc. lifted its position in shares of U.S. Physical Therapy by 35.7% during the 2nd quarter. Assetmark Inc. now owns 570 shares of the company's stock worth $45,000 after buying an additional 150 shares during the last quarter.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.